Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events international congress parkinson’s disease movement disorders mds virtual
… on the genetic and immunological influences in infectious disease outcomes at the University of North Carolina (UNC) at … including leading and managing her local chapter of the international conference ComSciCon, interning and writing for …
… Ophthalmology Oncology Medical Technologies Infectious Disease Diabetes & Endocrine Disorders Dermatology CNS/Neurology Cardiovascular … to valuable new health care technologies. Ms. Mladsi’s training is in economics and applied biostatistics, with an …
… health economic models have later been used in the company's health technology assessment submissions. Dr. Brodtkorb has … alcohol dependence, major depressive disorder, Alzheimer’s disease, dermatology, multiple sclerosis, cardiology, …
Qiang (Neal) Hao Health Economics Telecommuter - USA PhD, Health Policy and Administration Pennsylvania State University, University Park, PA MS, Economics and Quantitative Economics State University of New York at Buffalo, Buffalo, NY BA, Economics …
… for price negotiation: orphan drugs approved for only one disease or condition, plasma-derived products, and small …
… a rare cancer, generally diagnosed at early stages of the disease when prognosis is favorable. Mutations in the RET …
… Given the human and economic burden of vaccine-preventable disease, understanding the factors behind these low coverage …
… often included health states defined by levels of disease and treatment response. However, vague definitions of disease control and a lack of consensus on treatment response … on positioning biologics and creating clear definitions of disease control and treatment response. Further research on …
… HS in 2005, he has focused on safety studies evaluating disease natural history and incidence of and risk factors for … development of field procedures manuals and technical user's guides. Mr. Midkiff has traveled extensively in order to coordinate and actively participate in national and international trainings and meetings, as well as for study …
JCA Strategy and Planning The launch of Joint Clinical Assessments in 2025 represents a significant change to the marketing authorization process in the EU. It is critical that drug and device developers become informed on the latest guidance to be …